Acquired ribosomopathies in leukemia and solid tumors.

Related Articles

Acquired ribosomopathies in leukemia and solid tumors.

Hematology Am Soc Hematol Educ Program. 2017 Dec 08;2017(1):716-719

Authors: Vlachos A

Abstract
A mutation in the gene encoding the small subunit-associated ribosomal protein RPS19, leading to RPS19 haploinsufficiency, is one of the ribosomal protein gene defects responsible for the rare inherited bone marrow failure syndrome Diamond Blackfan anemia (DBA). Additional inherited and acquired defects in ribosomal proteins (RPs) continue to be identified and are the basis for a new class of diseases called the ribosomopathies. Acquired RPS14 haploinsufficiency has been found to be causative of the bone marrow failure found in 5q- myelodysplastic syndromes. Both under- and overexpression of RPs have also been implicated in several malignancies. This review will describe the somatic ribosomopathies that have been found to be associated with a variety of solid tumors as well as leukemia and will review cancers in which over- or underexpression of these proteins seem to be associated with outcome.

PMID: 29222326 [PubMed - in process]

http://ift.tt/2Bsc2NR